The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 9, 1996, Pages 384-389

  Branchi, A ^a   Rovellini, A ^a   Fiorenza, A M ^b   Maraffi, F ^c   Gandini, R ^c   Sommariva, D ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Bollate Hospital   (Italy)

^c V BUZZI CHILDREN S HOSPITAL   (Italy)

Author keywords

Apoprotein A I; HDL cholesterol; Simvastatin

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTILIPEMIC AGENTS; APOPROTEINS; CHOLESTEROL, HDL; DIET, FAT-RESTRICTED; FEMALE; HUMANS; HYPERLIPIDEMIAS; LOVASTATIN; MALE; MIDDLE AGED; SIMVASTATIN; TRIGLYCERIDES;

EID: 0029792131     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Arad Y, Ramakrishnan R, Ginsberg HN 1990 Lovastatin therapy reduces low density lipoprotein apo B levels in subjects with combined hyperlipidemia by reducing the production of apo B-containing lipoproteins: implications for the pathophysiology of apo B production. J Lipid Res 31: 567-582
2. Castelli WP, Garrison RJ, Wilson PWF. Abbott RD, Kalousdian S, Kannel WB 1986 Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835-2838
3. Desager JP, Horsmans Y, Harvengt C 1991 Lecithin:cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol. J Clin Pharmacol 31: 537-542
4. Franceschini G, Maderna P, Sirtori CR 1991 Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis 88: 99-107
5. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18: 499-502
6. Gardner MJ, Altman DG 1989 Statistics with confidence. (CIA): Software package. Version 1.0 Latimer Trend, Plymouth
7. Gordon D, Rifkind BM 1989 High density lipoproteins - the clinical implications of recent studies. N Engl J Med 321: 1311-1315
8. Grundy SM 1988 HMG-COA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319: 24-33
9. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Nakamura H 1995 Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis 114: 223-234
10. Hunninghake DB 1992 HMG-COA reductase inhibitors. Curr Opin Lipidol 3: 22-28
11. Illingworth DR, Bacon S, Pappu AS, Sexton GJ 1992 Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia. Eur J Clin Pharmacol 96: 53-64
12. Mann C, Yen FT, Grant AM, Bihain BE 1991 Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 88: 2059-2066
13. Miettinen TA 1991 Inhibition of cholesterol absorption by HMG-COA reductase inhibitors. Eur J Clin Pharmacol 40 (Suppl 1): S19-S21
14. Neuman MP, Neuman HR, Neuman J 1991 Significant increase of high-density lipoprotein-cholesterol under prolonged simvastatin treatment. Atherosclerosis 91: 11-19
15. Nozaki S, Vega GL, Haddox RJ, Dolan ET, Grundy SM 1990 Influence of lovastatin on concentrations and compositions of lipoprotein subfractions. Atherosclerosis 84: 101-110
16. Owens D, Collins P, Johnson A, Tighe O, Robinson K, Tomkin GH 1991 Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms. Biochem Biophys Acta 1082: 303-309
17. Pietro DA, Alexander S, Mantell G, Staggers JE, Cook TJ for Simvastatin Multicenter Study Group II 1989 Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II). Am J Cardiol 63: 682-686
18. Silverman DI, Ginsburg GS, Pasternak KC 1993 High-density lipoprotein subfractions. Am J Med 94: 636-645
19. Snedecor GW, Cochran WG 1967 Statistical methods (6th edn). Iowa State University Press, Ames, Iowa
20. Sommariva D, Bronchi A, Tirrito M, Bonfiglioli D, Pini C, Scandiani L, Ottomano C, Fasoli A 1988 Relationship of serum triglyceride concentration to lipoprotein composition and concentration in normolipidemic and hyperlipidemic subjects. Res Clin Lab 18: 281-290
21. Tall AR 1986 Plasma lipid transfer proteins. J Lipid Res 27: 361-367
22. The European Study Group 1992 Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia. (Multicountry Comparative Study). Am J Cardiol 70: 1281-1286
23. The Simvastatin Pravastatin Study Group 1993 Comparison of the efficacy, safety, and comparability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol 71: 1408-1414
24. Vega GL, Krauss RM, Grundy SM 1990 Pravastatin therapy in primary moderate hypercholesterolemia: changes in metabolism of apolipoprotein B-containing lipoproteins. J Intern Med 227: 81-94